StockData
CapsoVision, Inc logo

CapsoVision, Inc (CV) stock

CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30733% above fair value
$6.65+0.18 (+2.78%)

Close on Nov 17, 2026Market cap $332.81MP/E –Yield –

CapsoVision operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

CapsoVision's operating income for the twelve months ending Jun 30, 2026 was -$30.16M. For fiscal 2025 it was -$25.52M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$25.52M–
FY2024Dec 31, 2024-$19.92M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.58M–
Q1 FY2026Mar 31, 2026-$7.09M–
Q4 FY2025Dec 31, 2025-$7.46M–
Q3 FY2025Sep 30, 2025-$8.02M–
Q2 FY2025Jun 30, 2025-$4.65M–
Q1 FY2025Mar 31, 2025-$5.38M–
Q4 FY2024Dec 31, 2024-$4.63M–
Q3 FY2024Sep 30, 2024-$5.80M–
Q2 FY2024Jun 30, 2024-$5.27M–

More CapsoVision figures

See a number that looks wrong?